日本語 >>
TOP page
Journal
Presentation
Belonging society
(Last updated : 2023-06-05 14:44:11)
Masahiro Yamamura
Department
Kawasaki Medical School Kawasaki Medical School, Department of Clinical Oncology,
Position
Assistant Professor
■
Journal
1.
2022/09/29
Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay
2.
2022/02
Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate- Activated Killer (ZAK) Cells – An Analysis for Patients With Incurable Pancreatic Cancer
3.
2022
Advanced gastrointestinal stromal tumor with intracerebral hemorrhage during sunitinib treatment
4.
2022
Severe thrombocytopenia and maculopapular erythema-induced by regorafenib in a patient with advanced gastrointestinal stromal tumor
5.
2022
Sorafenib-induced apoptosis in colonic neuroendocrine carcinoma cells
6.
2021/12/22
Impacts of SNPs on adverse events and trough concentration of imatinib in patients with gastrointestinal stromal tumors
7.
2020/10/24
Nanoparticle-mediated delivery of 2-deoxy-D-glucose induces antitumor immunity and cytotoxicity in liver tumors in mice.
8.
2020/08/24
Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study
9.
2020/04
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world
10.
2019/08
Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts.
11.
2019/03
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
12.
2018/11
Extracellular S100A11 plays a critical role in spread of the fibroblast population in pancreatic cancers
13.
2018/01
DKK3 Overexpression Increases Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
14.
2017/03
Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device
15.
2015/09
Current Cancer Immunotherapy Using Activated Lymphocytes -Do Lymphocytes Actually Recognize Cancer Cells?
16.
2015/02
Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors
17.
2014/11
Imatinib Plasma Levels during Successful Long-Term Treatment of Metastatic Gastrointestinal Stromal Tumors
18.
2014/10
Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature
19.
2014/06
Adoptive immunotherapy using autologous lymphocytes activated ex vivo with antigen stimulation for patients with incurable cancer
20.
2014/04
Metformin suppresses sonic hedgehog expression in pancreatic cancer cells
21.
2013/10
Eicosapentaenoic Acid Modifies Cytokine Activity and Inhibits Cell Proliferation in an Oesophageal Cancer Cell Line
22.
2011/11
Characterization of novel germline c-kit gene mutation, KIT-Tyr553Cys, observed in a family with multiple gastrointestinal stromal tumors
23.
2006/12
Induction of Dihydropyrimidine Dehydrogenase Expression by Mitomycin C in Colorectal Cancer
24.
2006
Lower esophageal sphincter- and vagus-preserving proximal partial gastrectomy for early cancer of the gastric cardia.
25.
2005/10
In vitro detection of cross-resistant and non-cross-resistant agents with fluorouracil for patients with colorectal cancer.
26.
2005/02
Surgical oncotaxis--excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients.
Display 5 items
Display all(26)
■
Presentation
1.
2023/03/15
Pre-treatment PD-1 lymphocyte ratio in blood may predict clinical outcome of gastric cancer patients under Nivolumab monotherapy (Speech,General)
2.
2022/02/17
Fluctuating PD-1 ratio in blood may predict clinical outcome of upper gastrointestinal cancer patients under ICI therapy (Poster notice,General)
3.
2020/10/01
DKK3 regulates malignant property of head and neck squamous cell carcinoma via phosphorylation of Akt. (Poster notice,General)
4.
2020/10/01
Eextracellular S100A11 upregulates mobility of pancreatic cancer cells through activation of surrounding fibroblasts. (Poster notice,General)
5.
2020/10/01
HSP90 inhibition suppresses not only cell proliferation but also chemotaxis in esophageal squamous cell carcinoma (Speech,General)
6.
2020/10/01
NOX4 on lymphatic endothelial cells (LEC) plays an important role on the migration of pancreatic cancer cells towards lymphatics. (Speech,General)
7.
2019/07/05
Poor prognosis of hypermutant colorectal cancer with KRAS mutations: A retrospective analysis of 1,052 Japanese colorectal cancer patients without treatment of immuno-checkpoint inhibitors (Poster notice,General)
8.
2019/04/01
Comparing effects of small molecular weight compounds on proliferation and chemotaxis of pancreatic cancer cells (Poster notice,General)
9.
2018/11/24
Efficacy of Ramucirumab in combination with second-line or salvage-line FOLFIRI in patients with metastatic colorectal cancer. (Poster notice,General)
10.
2018/11/10
Clinico-pathological features of hypermutant colorectal cancers analyzed over 1000 colorectal cancer (Speech,Panelist at Symposium/Workshop (Other))
11.
2018/10/22
Heat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventional receptor tyrosine kinase inhibitors (Poster notice,General)
12.
2018/10/21
Distinct Clinico-pathological Features of Hypermutant Colorectal Cancers with POLE Pathogenic Mutations, Lynch Syndrome and Sporadic MSI Analyzed over 1,000 Colorectal Cancer Patients (Poster notice,General)
13.
2018/09/27
Migration of Pancreatic Cancer cell BxPC-3 is suppressed by ROS (Speech,General)
14.
2017/04/27
Knockdown of DKK3 gene reduces malignant properties of oral squamous cell carcinoma-derived cells (Poster notice,General)
15.
2017/04/03
Heat shock protein 90 inhibitors suppress PDGFRA reactivation and other receptor tyrosine kinase activation important in drug resistant gastrointestinal stromal tumors. (Poster notice,General)
16.
2016/10/06
Exploring serum factors for evoking and promoting cancer metastasis (Poster notice,General)
17.
2016/10/06
HSP90 inhibitor inhibit the activation of proliferation, chemotaxis and EMT in pancreatic cancer cells (Speech,General)
18.
2016/05/18
HSP90 inhibitor inhibit the activation of multiple kinase pathways and migration of pancreatic
cancer cells. (Poster notice,General)
19.
2015/12/20
Imatinib plasma levels and clinical features of successful long-term treatment of metastatic gastrointestinal stromal tumors (Poster notice,General)
20.
2015/12/20
Successful treatment of everolimus for a renal impairment patient with neuroendocrine tumor (Poster notice,General)
21.
2015/10/10
Functional analyses of DKK3 in oral squamous cell carcinoma cell lines (Poster notice,General)
22.
2015/10/09
HSP90 inhibitor inhibit the activation of multiple kinase pathways of pancreatic cancer cells (Speech,General)
23.
2015/07/10
Suppressing pancreatic cancer metastasis by small molecular compunds (Poster notice,General)
24.
2015/04/20
The new molecular target therapy of Hsp90 inhibition in esophageal squamous cell carcinoma (Poster notice,General)
25.
2014/11/25
Basic research for inhibiting pancreatic cancer metastasis: Gemcitabine vs Dasatinib (Poster notice,General)
26.
2014/11/13
Effect of HSP90 inhibitor on proliferation and migration in esophageal squamous cell carcinoma (Speech,General)
27.
2014/09/25
Antitumor effect of HSP90 inhibitor against esophageal cancer (Poster notice,General)
28.
2014/07/17
Clinicopathological study of gastrointestinal neuroendocrine tumor. (Poster notice,General)
29.
2013/02/25
Possibility of combination therapy of molecular targeted drugs for gastrointestinal stromal tumor. (Poster notice,General)
30.
2012/09/20
Antitumor effect of Hsp90 inhibitor in neuroendocrine tumor (Poster notice,General)
31.
2011/07/01
Wnt signaling during transition from cell proliferation to differentiation in myoblast cells. (Poster notice,General)
32.
2011/07/01
Wnt signaling involved in gastrointestinal neuroendocrine tumors. (Poster notice,General)
33.
2010/09/04
Cancer vaccine in combination with Anti-CD25 antibody for advanced esophageal squamous cell carcinoma. –a case of the prolonged stable disease (Poster notice)
34.
2010/08/25
A case with postoperative bone metastasis of gastrointestinal stromal tumor (GIST) expressing exon 8 mutation of KIT (Poster notice)
35.
2010/08/25
Cancer Vaccine in Combination with Anti-CD25 Antibody for Advanced Esophageal Squamous Cell Carcinomas –A Case of the Prolonged Stable Disease- (Poster notice)
36.
2008/03/24
Antitumor effect and signaling mechanism of tranilast in gastric cancer cell lines. (Poster notice,General)
37.
2008/03/24
Interaction of Wnt4 with myostatin signaling during myogenic differentiation of skeletal muscle. (Poster notice,General)
38.
2007/06/21
Different beta-catenin immunoexpression in gastrointestinal neuroendcrine tumors (carcinoid tumors). (Poster notice,General)
39.
2007/06/21
Nuclear expression of beta-catenin in oral leukoplakia with or without dysplasia (Poster notice,General)
40.
2006/02/22
A pilot study of combined chemotherapy with docetaxel and nedaplatin as a second line for unresectable or recurrent esophageal carcinoma
41.
2006/02/22
Excessive surgical stress of thoraco-laparotomy contributes to enhancing tumor metastasis and poor prognosis(surgical or stress oncotaxis) (Poster notice)
42.
2006/02/22
How to control cytokine storm after thoraco-laparotomy, experimentally and clinically
43.
2005/05/05
Technique and results of LES/vagus nerve-preserving proximal partial gastrectomy for cardia cancer
44.
2004/06/05
Determination of a second-line chemotherapy agent for patients with colorectal cancer (CRC) after fluorouracil failure (General)
45.
2004/06/02
Duplication of common bile duct: A review of the literature (General)
46.
2004/06/02
Inflammatory pseudotumor of the spleen: report of three cases (General)
47.
2003/05/31
Cender differences in the dihydropyrimidine dehydrogenase(DPD) expression and 5-fluorouracil (5-FU) sensitivity of colorectal cancers (CRCs).
Display 5 items
Display all(47)
■
Belonging society
1.
Japan Surgical Society
2.
The Japanese Gastroenterological Association
3.
Japan Society of Clinical Oncology
4.
Japanese Cancer Association